Kolon TissueGene Amends Lawsuit Disclosure: Claim Amount Slightly Reduced and Some Plaintiffs Withdraw
Kolon TissueGene has filed a correction disclosure regarding a damages lawsuit filed in 2019, amending the claim amount and number of plaintiffs.
The correction follows additional withdrawals by some plaintiffs, reducing the claim amount from 9.15 billion won to 9.13 billion won, with the ratio to equity falling to 4.11%.
The lawsuit was originally filed in 2019, and the company plans to respond actively through legal proceedings.
[AI Summary]The reduction in the claim amount is negligible relative to the company's market capitalization, thus having no material impact on the stock price. The litigation status remains unchanged, requiring no special investor attention.
KOSDAQ Filing Information
[Correction of Description] Filing of Lawsuits, etc. and Application (Claims of Specified Amount or More)